About Contact Us Careers

Human Organoids Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3240
Published Date: Jun 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Human Organoids Landscape

BioVT LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Thermo Fisher Scientific Inc.
Corning Incorporated
Emulate Bio
Organovo Holdings Inc.
Zen-Bio Inc
Hurel Corporation
Cellink AB
Biopredic International

Browse Key Market Insights with Data Illustration:

Human Organoids Market Size & Share, Growth Forecasts 2036

In the News

Thermo Fisher Scientific declared to acquire PPD, Inc. for USD 47.50 per share. This acquisition establishes Thermo Fisher as a global leader in the clinical research service industry.
CELLINK announced its acquisition of MatTek Corporation to expand its portfolio to advance in-vitro technology.

Author Credits: Radhika Pawar

Report ID: 3240
Published Date: Jun 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of human organoids is estimated at USD 2.8 Billion.

The human organoids market size was over USD 2.37 Billion in 2023 and is set to cross USD 21.06 Billion by the end of 2036, growing at more than 18.3% CAGR during the forecast period i.e., between 2024-2036. The rising incidence of infectious diseases and the growing investment in the advancement of technologies are the major factors driving the market growth.

Asia Pacific is projected to hold largest industry share by 2036, due to rising need for organ transplantation and donation.

BioVT LLC, Thermo Fisher Scientific Inc., Corning Incorporated, Emulate Bio, Organovo Holdings Inc., Zen-Bio Inc, Hurel Corporation, Cellink AB, Biopredic International

Inquiry Before Buying Request Free Sample